association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure

Background: Left ventricular ejection fraction (LVEF) is the most widely used parameter to evaluate the cardiac function in patients with heart failure (HF). However, the association between LVEF and contrast-induced nephropathy (CIN) of CIN. In addition, reduced LVEF was an independent predictor of long-term mortality following cardiac catheterization.

[1]  Qianzhou Lv,et al.  Drug Effects and Clinical Investigations for Contrast-Induced Nephropathy After Coronary Angiography or Percutaneous Coronary Intervention in Patients With Diabetes , 2017, American journal of therapeutics.

[2]  H. Suryapranata,et al.  Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention , 2017, Angiology.

[3]  N. Tan,et al.  A New Preprocedure Risk Score for Predicting Contrast-Induced Acute Kidney Injury. , 2017, The Canadian journal of cardiology.

[4]  G. Keren,et al.  Echocardiographic correlates of left ventricular filling pressures and acute cardio-renal syndrome in ST segment elevation myocardial infarction patients , 2017, Clinical Research in Cardiology.

[5]  C. Siu,et al.  Heart failure across Asia: Same healthcare burden but differences in organization of care. , 2016, International journal of cardiology.

[6]  W. Shimizu,et al.  Regional and ethnic differences among patients with heart failure in Asia: the Asian sudden cardiac death in heart failure registry. , 2016, European heart journal.

[7]  H. Ly,et al.  Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies. , 2016, The Canadian journal of cardiology.

[8]  G. Stone,et al.  Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST‐segment elevation myocardial infarction: Results of the HORIZONS‐AMI trial , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  Y. Arbel,et al.  Association of left ventricular function and acute kidney injury among ST-elevation myocardial infarction patients treated by primary percutaneous intervention. , 2015, The American journal of cardiology.

[10]  C. Lam,et al.  The middle child in heart failure: heart failure with mid‐range ejection fraction (40–50%) , 2014, European journal of heart failure.

[11]  D. McManus,et al.  Long-term survival for patients with acute decompensated heart failure according to ejection fraction findings. , 2014, The American journal of cardiology.

[12]  J. Daubert,et al.  Association between cardiovascular vs. non‐cardiovascular co‐morbidities and outcomes in heart failure with preserved ejection fraction , 2014, European journal of heart failure.

[13]  M. B. Demirçelik,et al.  Association Between N‐Terminal Pro‐Brain Natriuretic Peptide Levels and Contrast‐Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome , 2014, Clinical cardiology.

[14]  A. Durante,et al.  Contrast-Induced Nephropathy in Percutaneous Coronary Interventions: Pathogenesis, Risk Factors, Outcome, Prevention and Treatment , 2014, Cardiology.

[15]  Sushrut S Waikar,et al.  Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[16]  G. Andò,et al.  Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast‐induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[17]  T. Uejima,et al.  Clinical characteristics and long-term clinical outcomes of Japanese heart failure patients with preserved versus reduced left ventricular ejection fraction: a prospective cohort of Shinken Database 2004-2011. , 2013, Journal of cardiology.

[18]  Hongliang Cong,et al.  Risk Score for the Prediction of Contrast-Induced Nephropathy in Elderly Patients Undergoing Percutaneous Coronary Intervention , 2013, Angiology.

[19]  P. Aspelin,et al.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines , 2011, European Radiology.

[20]  R. Vasan,et al.  Epidemiology and clinical course of heart failure with preserved ejection fraction , 2011, European journal of heart failure.

[21]  Ari B. Geller,et al.  Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease , 2010, International Urology and Nephrology.

[22]  P. Ponikowski,et al.  Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative , 2009, European heart journal.

[23]  A. Courtney,et al.  Using estimated glomerular filtration rate (eGFR) to help manage patients with chronic kidney disease , 2007, The Ulster medical journal.

[24]  Michael Böhm,et al.  Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology , 2007, European journal of heart failure.

[25]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[26]  J. Fleg,et al.  Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function. , 2006, American heart journal.

[27]  F. Stacul.  Reducing the Risks for Contrast-Induced Nephropathy , 2005, CardioVascular and Interventional Radiology.

[28]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[29]  K. Swedberg,et al.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. , 2004, Journal of the American College of Cardiology.

[30]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[31]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[32]  S G Thompson,et al.  Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.

[33]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.

[34]  K. Tong,et al.  Comparison of Characteristics and Outcomes of Heart Failure Patients With Preserved Versus Reduced Ejection Fraction in a Multiethnic Southeast Asian Cohort. , 2016, The American journal of cardiology.

[35]  Michael E Matheny,et al.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. , 2014, JACC. Cardiovascular interventions.

[36]  Jiyan Chen,et al.  Contrast medium volume to creatinine clearance ratio: A predictor of contrast‐induced nephropathy in the first 72 hours following percutaneous coronary intervention , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.